{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-060364","form_type":"8-K","ticker":"RIBB","cik":"0002035016","company_name":"Ribbon Acquisition Corp.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.881764+00:00","generated_at":"2026-05-18T10:54:08.371982+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ribbon Acquisition Corp. to combine with DRC Medicine in $350M equity value SPAC merger","bullets":["DRC Medicine designs AI-powered allergy and infection diagnostic kits and protective face masks.","Equity value set at $350M; consideration determined by dividing $350M by redemption price per share.","Post-closing board: Sponsor appoints 1 director, DRC appoints 4 directors (3 independent).","Lock-up of 6 months from closing for certain shareholders and Sponsor.","Closing requires SPAC shareholder approval, SEC registration statement effectiveness, and Nasdaq listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-060364","json":"https://secwatch.observer/filing/0001213900-25-060364.json","markdown":"https://secwatch.observer/filing/0001213900-25-060364.md","text":"https://secwatch.observer/filing/0001213900-25-060364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2035016/000121390025060364/0001213900-25-060364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2035016/000121390025060364/ea0247714-8k425_ribbon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:54:08.371982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}